Bristol-Myers Squibb (BMY) Stock Forecast & Price Target

BMY$63.43+1.11 +1.78%
Drug Manufacturers - GeneralLarge CapValue StockHigh Quality
Compare
Market cap$129.66BEnterprise value$166.45BRevenue (TTM)$50.03BMarket positionTop 25%

Score

61
Neutral
Value
64
Quality
72
Growth
47

Bristol-Myers Squibb Company price target

BMY
Low$41.00
Average$66.08
High$78.00
Upside vs current price+4.2%

The average target of $66.08 is +4.2% versus the current BMY price of $63.43.

Bristol-Myers Squibb Company analyst ratings

RatingAnalysts
Strong buy4
Buy6
Hold17
Sell1
Strong sell0
ConsensusHold

28 analysts cover BMY.

Bristol-Myers Squibb Company EPS and revenue estimates

The estimate table for the Bristol-Myers Squibb Company keeps 2026 EPS $6.44, 2027 EPS $6.66, and years with fewer than three analysts are not filled in.

Fiscal yearEPS estimateRevenue estimate
2026$6.44$50.11B
2027$6.66$48.74B

Is Bristol-Myers Squibb Company a buy or sell?

Of the 28 analysts covering Bristol-Myers Squibb Company, 10 rate it a buy (4 strong buy and 6 buy), 17 rate it a hold, and 1 rates it a sell (1 sell and 0 strong sell).

The BMY consensus label is Hold, beside 10 buy-side ratings and 1 sell-side ratings.

The average target of $66.08 implies +4.2% versus the current price of $63.43.

the Bristol-Myers Squibb Company closes with 10 buy-side ratings and 1 on the sell side. The headcount is Hold.

Reading the Bristol-Myers Squibb Company forecast

Analysts are far apart on BMY. The published low is $41.00, the average is $66.08, and the high is $78.00.

From today's $63.43 print, the BMY average target is +4.2% away.

Buy and the rest of the scale both have a real share of BMY: 10 of 28 analysts are on the buy side, 17 are at hold, and 1 is on the sell side, and the published consensus is Hold.

BMY has both upgrades (1) and downgrades (1) in the recent window.

BMY targets have eased: $62.83 in the last month against $67.00 over the last quarter.

Coverage of BMY is broad at 28 analysts, and the average is a crowd rather than a single desk.

Bristol-Myers Squibb Company forecast questions

What is the BMY price target?

The published range for BMY is $41.00 to $78.00, with an average of $66.08. That average is +4.2% versus the current price of $63.43.

Is Bristol-Myers Squibb Company a buy or sell?

Of the 28 analysts covering Bristol-Myers Squibb Company, 10 rate it a buy, 17 rate it a hold, and 1 rates it a sell. The consensus is Hold, which for BMY is 10 on the buy side, 17 at hold, and 1 on the sell side.

What is the EPS estimate for Bristol-Myers Squibb Company?

Analyst EPS estimates for Bristol-Myers Squibb Company: 2026 $6.44, 2027 $6.66.

What is the revenue estimate for Bristol-Myers Squibb Company?

Analyst revenue estimates for Bristol-Myers Squibb Company: 2026 $50.11B, 2027 $48.74B.

How many analysts cover BMY?

28 analysts cover BMY. Their consensus on BMY is Hold, across those 28.

BMY price $63.43 +1.11 +1.78%

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener